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Abstract
Background: Because treatment modalities for carbon monoxide (CO) poisoning, especially normobaric oxygen
and hyperbaric oxygen therapies, have limited effects and hyperbaric oxygen is not available at the scene where
treatment is most needed, we conducted a study to determine and compare rates of carboxyhemoglobin (COHb)
dissociation achieved in human in vitro blood samples under light radiation emitted at three levels of illuminance.
This was done with a view toward eventual on-site application.
Methods: We drew blood from 10 volunteers, prepared 10 red blood cell solutions, and subjected each solution
to a CO bubbling procedure to increase the COHb saturation. Samples of each bubbled solution were then divided
between 3 beakers (beakers A, B, and C) for a total of 30 beakers. The solution in each beaker was exposed to a
continuous flow of oxygen at 50 mL/min, and simultaneously for a period of 15 min, the beaker A and B solutions
were irradiated with light emitted at 500,000 and 100,000 lux, respectively, from a halogen light source. The beaker
C solutions were exposed to room light. At 3, 6, 9, 12, and 15 min, a 50-μL sample was pipetted from each of the
30 beakers for determination of its light absorbance and the COHb dissociation rate.
Results: Under each of the experimental conditions, dissociation progressed but at different rates, and starting at
3 min, the differences in rates between conditions were significant (P < 0.01). The dissociation rate was greatest
with light emitted at 500,000 lux.
Conclusions: Our results point toward the possibility of readily performed, acute photodissociation therapy for
patients with CO poisoning.
Abbreviations: CO, Carbon monoxide; COHb, Carboxyhemoglobin; HBO, Hyperbaric oxygen; NBO, Normobaric
oxygen; O2Hb, Oxyhemoglobin
Background
Awareness of the deadly effects of carbon monoxide
(CO) dates back to the time of the ancient Greeks and
Romans, when the gas was used for executions [1]. To
this day, CO poisoning remains one of the most common
types of poisoning, accounting for more than 60 % of
poisoning deaths in Japan, accidental or otherwise [2]. CO
is a tasteless, odorless, and non-irritating but highly toxic
gas that confers significant long-term morbidity and is
often associated with severe delayed neuropathology [3].
Despite the aggressive treatment strategies available, mor-
bidity and mortality rates attributable to CO poisoning
remain high [4].
Because of the intrinsic properties of CO and lack of
specific clinical features of CO poisoning, the condition
is difficult to detect, and it can mimic other common
disorders. Therefore, the true incidence of CO poison-
ing is unknown, and it is likely that many cases go
unrecognized. CO is a by-product of the incomplete
combustion of hydrocarbons, and it is commonly pro-
duced by domestic heating appliances and systems,
charcoal burning, fires, and car exhaust. CO poisoning
accounts for many deaths by suicide.* Correspondence: taku040@gmail.com1Medical Emergency and Disaster Center, Kawasaki Municipal Tama Hospital,
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CO toxicity results from the formation of a carbon-
hemoglobin complex, carboxyhemoglobin (COHb), which
is over 200-fold more stable than oxyhemoglobin (O2Hb)
[5, 6]. An increased blood COHb concentration will
compromise oxygen transport by hemoglobin and thus
decrease oxygen delivery to vital organs and tissues. Fur-
thermore, not only does COHb have a long half-life, but
at a 20 % concentration, more than 8 h may be required
for CO to fully dissociate from the complexed hemoglobin
[7]. The importance of effectively eliminating the toxic ef-
fect of CO cannot be overemphasized. However, present
treatment modalities, especially hyperbaric oxygen (HBO)
and normobaric oxygen (NBO) therapies, have limited ef-
fects, and HBO therapy especially remains controversial
and not readily available at the scene where treatment is
most needed. Phototherapy, specifically photodissociation
of COHb, appears to be a viable alternative because there
are no known complications. With a view toward use in
clinical cases of CO poisoning, we conducted a study to
determine and compare rates of COHb dissociation
achieved in human in vitro blood samples under light
radiation emitted from two different light sources at three
different levels of illuminance.
Methods
Blood samples
Under approval granted by the Ethics Committee of
St. Marianna University School of Medicine, Japan, we
drew blood from 10 adult volunteers (smokers n = 2,
non-smokers n = 8) recruited from our staff. The volun-
teers ranged in age from 28 to 61 years, with a mean of
37.9 years. Thirty milliliters of blood was collected from
each volunteer by direct venipuncture of the brachial
vein, immediately anticoagulated with 0.1 mL heparin
(Novoheparin, Mochida Seiyaku, Tokyo, Japan), and
then washed. The specimen was then centrifuged at
3000 rpm for 10 min, the plasma supernatant was re-
moved, the erythrocytes were re-suspended in a 9-g/L
normal saline solution, and the suspension was centri-
fuged. This process was repeated three times before the
tube was inverted two or three times until the contents
were mixed to the point of turbidity. Next, 2 mL of the
red blood cell solution was pipetted out of the tube and
exposed continuously to 100 % pure oxygen at 60 mL/
min to produce 100 % O2-saturated hemoglobin (100 %
O2Hb) (Fig. 1).
CO bubbling
The remaining 28 mL of the red blood cell solution was
prepared for CO bubbling, a procedure that is designed
to increase the COHb saturation. The procedure con-
sists of the following series of steps: (1) the red blood
cell solution is placed at the bottom of a Ziploc freezer
bag, and a flexible, plastic spray nozzle belonging to a
CO canister (GL-Sciences, Ltd., Tokyo, Japan) is posi-
tioned at the mouth of the bag; (2) the air is squeezed
out of the bag, which is then sealed by hand, and to
avoid any tearing, the sealed bag is placed in a second
Ziploc bag, which is also sealed; (3) the nozzle is at-
tached to the CO canister, and CO is injected into the
bag until it is fully inflated (Fig. 2a); and (4) the CO-
inflated bag is then vigorously shaken for at least
Fig. 1 Flow diagram showing preparation of blood samples for exposure to the three different experimental conditions and the subsequent
determination of absorbance rates
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60 min, which we know will result in over 90 % COHb
production (Fig. 2b).
After the CO bubbling procedure, three separate 5-mL
samples of the solution were collected from the bag and
placed into three separate 20-mL beakers: beaker A,
beaker B, and beaker C. In all, 30 samples (3 samples ×
10 volunteers) were obtained, and each was placed in its
own beaker. A halogen light source (MegaLight 100,
SHOTT-MORITEX, Tokyo, Japan) attached to a 25-cm-
long flexible stainless steel gooseneck light guide was
placed 10 mm above the surface of each sample. The
light emitting end of the light guide was 6 mm in
diameter. We administered a continuous flow of oxygen
at 50 mL/min by plunging a copper nozzle (length
100 mm, diameter 4 mm) connected to an oxygen gas
cylinder into the red blood cell solution, and at the
same time, for a period of 15 min, we irradiated the
beaker A blood sample with light at a total luminance
of 500,000 lux and the beaker B sample with light at a
total luminance of 100,000 lux. The beaker C sample
was not irradiated but rather was left exposed to room
light (Fig. 2c, d). At 3-min intervals (3, 6, 9, 12, and
15 min), a 50-μL sample was pipetted out of each
beaker for determination of its light absorbance and its
CO dissociation rate.
A distance of 10 mm between the light guide tip and
the red blood cell surface is the optimal distance at
which the flexible light guide can safely emit light
without causing any blood splatter from the continuous
oxygen administration. Under the optical illumination
with 500,000 lux maintained for 15 min, the temperature
of the blood in the beakers was below 32 °C, and there-
fore, hemoglobin protein denaturation was not a con-
cern during the irradiation process. In addition, each
beaker was firmly sealed with aluminum foil to prevent
the escape of any irradiation light. The light reaches the
bottom of the beaker and there measures 50–60 lux.
Measurement of the photodissociation rate
It is well established that O2Hb and COHb each has its
own specific light absorption spectra that are character-
ized by a bimodal curve, each with two maximal spec-
trophotometrically determined absorption peaks: 540
and 576 nm for O2Hb and 538 and 568 nm for COHb.
The absorption spectra may be altered by varying the ra-
tio between the O2Hb and COHb concentrations, and
the morphology of the resulting waveforms will be by
modified accordingly. It is also known that a small amount
of sodium hydrosulfite can reduce O2Hb, thereby alter-
ing its absorption curve from a bimodal to a monomo-
dal wavelength with an absorption peak of 555 nm.
(Fig. 3) [8, 9].
Because the aim of this study was to determine the





Fig. 2 CO bubbling. a CO is injected into a Ziploc bag containing the red blood cell solution until the bag is fully inflated. b The inflated bag is
then vigorously shaken for at least 60 min, resulting in 90 % COHb production. c, d The sample solution, now in a beaker, is simultaneously exposed to
light (500,000 lux, 300,000 lux, or simply room light) and to a continuous flow of oxygen at 50 mL/min. The oxygen is delivered via a copper nozzle
connected to an oxygen gas cylinder
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light radiation, we selected a reduced O2Hb monomodal
curve absorption value of 555 nm and an absorption
value of 538 nm from the COHb bimodal curve. To this
end, we removed two samples of 50 μL each, one from
the previously prepared sample containing 100 % O2Hb,
and one from the CO-bubbling bag, and we placed these
samples in two separate test tubes before adding to
each of them 10 mL 0.1 % sodium carbonate and then
0.0275 g (1 micro-spoon) sodium hydrosulfite, and we
gently shook the samples for a few seconds. After
allowing the solution to settle for 15 min, the samples
were analyzed by spectrophotometry (BioSpectrometer
Basic, Eppendorf, Hamburg, Germany) so that we could
determine the parameters necessary to tabulate the
O2Hb (A0) and COHb (A100) constants that would be
needed to calculate the COHb dissociation rate.
A 50-μL sample was then collected every 3 min over a
period of 15 min (at 3, 6, 9, 12 and 15 min) from beaker
A, beaker B, and beaker C, and these samples were sub-
jected to the same buffering procedure described above.
Subsequently, all collected samples were subjected to
spectrophotometry in which the constant values were
used to determine the light absorbance spectrum (Ax) of
each sample.
Calculating CO saturation
For all samples, a bimodal curve was projected on a
Cartesian coordinate system visible on the spectropho-
tometer screen. The abscissa and ordinate axes represent
the wavelength and absorbance spectra, respectively. From
the given E555 and E568 wavelengths on the x axis, we
were able to identify the corresponding absorbance values
on the y axis for O2Hb and COHb in all samples tested.
Next, the respective constant values of A0 and A100 for
both O2Hb and COHb and the Ax values for the three
samples were calculated as follows: A0 = E538/E555,
A100 = E538/E555, and Ax = E538/E555, which were then
inserted and tabulated according to the following
COHb concentration equation: COHb (%) = (Ax − A0) /
(A100 − A0) * [9]. The value obtained is the dissociation
rate, and the rate was calculated for each of the 30 sam-
ples obtained at each of the various time points.
Statistical analysis
For each of the 10 samples obtained at each time point,
the mean ± SE COHb dissociation rate was calculated.
The rates were then plotted per condition (i.e., per bea-
ker A, B, or C), per time point. Differences in the mean
± SE dissociation rate between the three conditions were
analyzed by repeated-measures ANOVA and Tukey’s
HSD test. Correlation between COHb saturation (shown
as a percentage) and the rate of change was tested by
Pearson’s correlation coefficient. All statistical analyses
were performed with Stat Flex ver. 6 (Artech Co., Ltd.,
Osaka, Japan), and P < 0.05 was considered significant.
Results
The study subjects, pertinent subject characteristics, and
individual study data are shown in Table 1. We drew
COHb dissociation curves (Fig. 4), and in comparing
these curves, we found that the dissociation rate deter-
mined for the beaker B (100,000 lux) samples was higher
than that for the beaker C (no irradiation) samples but
lower than that for the beaker A (500,000 lux) samples.
Under each of the experimental conditions, dissociation
progressed at different rates, but starting at 3 min, the
differences in rates between conditions were significant
(P < 0.01). Under exposure to light at 500,000 lux, the
dissociation rate decreased uniformly over time with no
noticeable difference between the time periods (Fig. 5).
Correlation between COHb saturation and the change in
the dissociation rate was significant for the 0–3-min
time period and the 12–15-min time period at P = 0.020
and P = 0.023, respectively (Fig. 6). Tukey’s multiple
comparisons analysis confirmed all statistical differences
that we found (P < 0.01).
Two of the volunteers were chronic heavy smokers
(subject 8: 2 packs/day for >30 years and subject 9: 1
pack/day for <10 years). Although the study group was
too small for meaningful comparison between smokers
and non-smokers, we noted that there was no significant
difference in dissociation rates between them.
Discussion
An estimated 58,000 emergency cases of CO poisoning
occur yearly in Japan, and the resulting estimated cost of
over 1 trillion 75 billion yen (8,743,000,000 USD) per
year [10] translates to a devastating socio-economic im-
pact. The symptoms of CO poisoning are non-specific
[11] and usually manifest when the CO concentration
rises above 10 % [12]. However, the reported association
Fig. 3 O2Hb, reduced O2Hb, and COHb waveforms
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between a patient’s blood level and that patient’s clinical
condition is poor [11, 12]. The general consensus is that
levels below 60 % do not result in coma or death [5]. In
non-smokers, the average CO concentration is 1 %,
whereas in heavy smokers, the average concentration
may reach 15 % [13]. CO causes hypoxia by combining
with hemoglobin in the blood to form COHb and
shifting the O2Hb dissociation curve to the left [13]. Its
affinity for hemoglobin is more than 200 times that of
oxygen [14], and it easily displaces oxygen from
hemoglobin, whereas COHb liberates CO very slowly,
resulting in the formation of COHb with even negli-
gible amounts of inhaled CO.
A small CO concentration can thus result in a toxic
level of COHb in the blood and lead to a decrease in the
amount of oxygen transported by hemoglobin to organs
and tissues. Up to 46 % of CO poisoning victims develop
delayed neuropsychological sequelae, including cognitive
deficits, motor disturbances, and vestibular abnormal-
ities [15]. Recent reports have also highlighted the con-
tribution of CO poisoning to the incidence of cardiac
events [16, 17] because the affinity of CO for myoglobin
is even greater than it is for Hb [1]. The binding of CO
to cardiac myoglobin can cause myocardial depression,
hypotension, arrhythmia, and even death [12].
To this day, one of the greatest challenges facing any
emergency department in cases of CO poisoning is the
need to promptly dissociate COHb to save patients’
lives. However, the treatment options in the emergency
physicians’ arsenal remain limited and are often associated
with severe side effects. Currently, the widely accepted
methods of management, NBO therapy and HBO therapy,
maximize the PaO2 level, thereby increasing O2Hb and
indirectly dissociating CO from COHb. NBO treatment
Table 1 Study subjects, pertinent subject characteristics, and individual study data
Subject Age (years) Sex Smoking 500,000 lux 100,000 lux No irradiation Change rate
3 min 15 min 3 min 15 min 3 min 15 min 0–3 min
1 44 M No 83.9 54.3 87.9 62.0 95.1 91.5 −5.38
2 41 F No 82.0 40.5 83.4 47.8 93.8 87.5 −6.02
3 28 F No 83.1 47.7 97.9 70.9 97.8 90.3 −5.64
4 42 M No 89.7 58.1 92.1 69.9 89.7 93.3 −3.43
5 40 F No 83.3 49.2 92.4 71.6 98.6 91.1 −5.58
6 30 M No 83.1 48.8 92.4 62.2 95.2 82.8 −5.64
7 32 M No 84.5 54.3 89.4 69.6 91.4 84.7 −5.18
8 30 M No 88.8 59.2 90.4 68.3 93.6 85.9 −3.72
9 61 M Yes 90.0 51.7 89.9 64.9 94.4 90.4 −3.35
10 31 M Yes 86.8 51.5 88.3 63.8 91.3 85.8 −4.41
Mean 37.9 – – 85.5 51.5 90.4 65.1 94.5 88.3 −4.84
Fig. 4 COHb dissociation curves plotted from mean ± SE dissociation rates for the total solution samples under the three different light exposure
conditions over a 15-min time period
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involves removing the patient from the source of exposure
and administering 100 % NBO for 4 to 6 h to remove over
90 % of the CO until the COHb concentration is less than
5 %. This regimen brings the half-life of COHb down to
74 min, as opposed to 320 min when breathing air [18].
The administration of oxygen speeds the elimination of
CO from the body. Without oxygen therapy, the elim-
ination half-life of CO is 4 to 5 h. Supplementation
with 100 % oxygen via a tight-fitting mask at NBO
pressure cuts the elimination half-life by approximately
50 %, whereas the use of HBO, i.e., the use of pure oxy-
gen to speed and enhance the body’s natural ability to
heal, at 2.5 atm decreases the elimination half-life to
20 min [18, 19]. However, HBO should be administered
within 6 h of exposure [7] for a duration of about 9 h [20],
and NBO should be administered when CO poisoning is
suspected and before laboratory confirmation. For de-
cades, HBO has been used for severe CO poisoning, but
its indication remains controversial [21–25] because of
the action of O2, which can result in oxygen toxicity sei-
zures and barotrauma, including pneumothorax and
hemorrhage. Furthermore, there is no real evidence that
HBO administration for CO poisoning reduces the inci-
dence of adverse neurologic outcomes [26].
Additionally, because of the equipment required and
its inconvenience, HBO therapy is often not a practical
option. HBO therapy requires special equipment, and
the institutions amenable to setting up a hyperbaric
chamber are limited. Currently in Japan, according to
the 2014 Japanese Society of Hyperbaric and Undersea
Fig. 5 Bar graph of the dissociation rate for each of the 3-minute time periods in samples exposed to light at 500,000 lux
Fig. 6 Correlation between CO saturation and the change in the dissociation rate during the 0–3-min and 12–15-min time periods
Tanaka et al. Journal of Intensive Care  (2016) 4:58 Page 6 of 8
Medicine registry, there are only 591 such facilities
nationwide [27]. Phototherapy, i.e., the use of visible
light to dissociate COHb, appears to be an appealing
and viable alternative for addressing CO poisoning. Un-
like NBO and HBO therapies, light irradiation therapy
works directly to dissociate CO from COHb; it does not
increase the PaO2, is not known to result in any compli-
cations, and appears to be safe.
The phototherapy method was originally developed
from an early hypothesis that light irradiation induces the
photodissociation of O2Hb. This hypothesis centers on
the fact that O2Hb absorbs the light radiation, and at a
probability of approximately 10 %, the photodissociation
will release the O2 molecule and restore hemoglobin [28].
Extrapolating this finding to COHb, and despite the simi-
larities in the absorption spectra of O2Hb and COHb, with
the significant difference (>10-fold) in the quantum yields
of photodissociation (which is 98 % for COHb), it
becomes possible to achieve selective decomposition of
COHb in the bloodstream with a minimum effect on the
O2Hb. The typical absorption spectra of O2Hb, COHb,
and reduced O2Hb, i.e., hemoglobin (Hb), in vitro are
shown in Fig. 3. Light irradiation dissociates CO from
the COHb complex and, with a constant O2 supply,
might re-establish the physiological O2Hb bond. Irradi-
ation of a COHb sample by light at various frequencies
has been documented to split the CO-Hb bond and
presumably restore O2Hb binding. In a landmark study,
Kashimura et al. [29] infused rats with synthetic artifi-
cial oxygen-carrying hemoglobin vesicles (HbV) and
exposed the rats to light of 500,000 lux and showed
that the COHb significantly dissociated (26.1 ± 2.4 %)
after 90 min of exposure.
We further explored the theory and experimental
success by examining the rate of dissociation achieved
with light emitted at different illuminances (0, 100,000,
and 500,000 lux) in human in vitro blood samples
highly saturated with COHb. Results of the light irradi-
ation were promising, with a relatively high dissociation
rate achieved with exposure to 500,000 lux within a
short (15-min) period.
In the in vitro study described herein, the Hb dissoci-
ated from the COHb complex presumably bound with
O2 and formed an O2Hb molecule, and the remaining
CO molecule most likely volatilized in air. In the human
body, photodecomposition of COHb and CO removal
will be most effective in the lungs and skin. However,
the unbound CO has a strong propensity for attachment
to Hb, and to prevent such de novo COHb complex for-
mation, sufficient O2 is required even in instances of low
COHb dissociation.
Our application of light irradiation to in vitro human
blood samples yielded encouraging data, and we con-
sider this a first step toward clinical application of
COHb dissociation for CO poisoning patients. The path
to clinical application must include both tests in large
animal models of CO poisoning and the conceptualization
and design of devices, particularly devices that can be used
at the scene.
The application of light irradiation to patients with a
high COHb concentration will require application of
the light as directly and closely as possible to the CO-
contaminated blood. The optimal phototherapy effect
will be achieved when the light is aimed as close to the
oxygen source as possible, namely the lungs. The au-
thors have envisioned a combination of options for the
urgent care of CO poisoning patients. One is an extra-
corporeal light radiation-emitting jacket that could
ideally be used to provide COHb dissociation therapy
at the scene of trauma, where the patient requires it
most. Its easy handling would allow paramedics to
place it on the patient during emergency transport to a
hospital or trauma center. The second is a light-
emitting catheter that, upon patient admission, could
be introduced into the pulmonary artery or the right
side of the heart to dissociate the COHb complex, thus
allowing O2 to bind with Hb while CO is exhaled
through the lungs. Development of a light radiation-
emitting jacket would need to take into account the op-
tical properties of the human skin for determination of
the effective wavelength of the penetrating radiation.
This could, however, be achieved by calculating the
action spectra of HbCO within the cutaneous layers.
Furthermore, the insertion and indwelling of the specif-
ically designed light radiation-emitting catheter would
probably require training.
Limitations
Our study had limitations. The first is the small sample
size, and the second is the inherent disadvantage of an
in vitro study, despite our use of human blood. Second,
the refraction and barrier effect that the light would
encounter in cutaneous and subcutaneous tissues of ac-
tual patients was not simulated. Third, medical histories,
including any underlying chronic disorders, medications,
or any prior hemoglobin studies, were not obtained from
the volunteers who donated blood.
Conclusions
We attempted and achieved photodissociation of COHb
in in vitro human blood samples by light irradiation. We
anticipate performing a larger study to further confirm
our results, which have convinced us of the real possibil-
ity of readily performed, acute photodissociation therap-
ies for patients with CO poisoning, therapies that are
imperative if we wish to meet the challenge of saving the
lives of individuals exposed to CO.
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